医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ZRG Partners Life Sciences Hiring Index Shows Modest Gains in 4th Quarter

2014年02月07日 AM01:25
このエントリーをはてなブックマークに追加


 

WEST ORANGE, N.J.

ZRG Partners, Inc. announces the results of its fourth quarter Global Life Sciences Hiring Index. Q4 reflects an overall gain in hiring, with Pharma activity over the long term reaching an all-time index high. Meanwhile R&D hiring took a hit dropping 15% from the previous quarter. The Asia Pacific Region saw significant hiring in Q4, more than 25%, with most being attributed to the Sales and Marketing function.

ZRG Managing Director David Fortier commented, “The results of this latest index correlate with the broader economy – inconsistencies across regions, sectors, and functions along with the continuation of a longer term trend of slow, steady, but uneven growth. The positive to take from these numbers is some robust hiring in selected functions within pharmaceuticals and a return of hiring in the commercial function indicating expectations of growth for some companies.”

About ZRG Partners

ZRG Partners, Inc. is a global authority on talent management issues in the Life Sciences, Pharmaceutical and Medical markets. ZRG provides its clients with specialized global market expertise in executive recruitment, consulting and advisory work with a focus on data and analytics to drive great business decisions.

The Global Life Sciences Hiring Index analysis utilizes a proprietary algorithm that looks at confidential hiring within selected benchmark companies in three distinct segments. The companies in the Index generate over $634 billion in revenues and employ over 1,300,000 people globally. ZRG Partners conducts extensive direct market research in developing the data that drives the Index.

For more information about ZRG please go to www.zrgpartners.com

CONTACT

ZRG Partners
Adam
El Din
, +41-22-319-3304
European President and Global Practice
Head of Life Sciences
or
David
Fortier
, +1-202-525-1341
Managing Director

同じカテゴリーの記事 

  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
  • Masimo创始人兼首席执行官Joe Kiani将在智利举行的全球患者安全峰会上谈论人工智能
  • マシモ創業者兼最高経営責任者(CEO)のジョー・キアニがチリで開催される世界患者安全サミットでAIについて講演
  • Codone Biotech to Present Data on its Suppressor-tRNA Platform in Disease Models with Nonsense Mutations (Premature Termination Codons)